Literature DB >> 20633803

Treatment of psoriasis with cyclosporine in patients with hepatitis C infection: risk or opportunity?

Vito Di Lernia, Giuseppe Albertini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20633803     DOI： 10.1016/j.jaad.2009.11.593

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

Review 1.  Management of psoriasis patients with hepatitis B or hepatitis C virus infection.

Authors:  Claudio Bonifati; Viviana Lora; Dario Graceffa; Lorenzo Nosotti
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

2.  Cyclosporine as monotherapy for psoriasis in the setting of chronic HCV infection: a forgotten therapeutical option.

Authors:  Alexandra Maria Giovanna Brunasso; Paolo Michetti; Laura Fancelli; Cesare Massone
Journal:  Hepat Mon       Date:  2012-05-30       Impact factor: 0.660

3.  Covid-19 infection in psoriasis patients treated with cyclosporin.

Authors:  Vito Di Lernia; Mohamad Goldust; Claudio Feliciani
Journal:  Dermatol Ther       Date:  2020-06-24       Impact factor: 3.858
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.